Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with Myeloma.

Fluorodeoxyglucose F18 Hematopoietic Stem Cell Transplantation Humans Magnetic Resonance Imaging Male Middle Aged Multiple Myeloma / diagnostic imaging Positron Emission Tomography Computed Tomography Prospective Studies Transplantation, Autologous
Bone Marrow Hematologic Diseases MR-Imaging Oncology Skeletal-Appendicular Skeletal-Axial

Journal

Radiology. Imaging cancer
ISSN: 2638-616X
Titre abrégé: Radiol Imaging Cancer
Pays: United States
ID NLM: 101765309

Informations de publication

Date de publication:
09 2021
Historique:
entrez: 24 9 2021
pubmed: 25 9 2021
medline: 3 11 2021
Statut: ppublish

Résumé

Purpose To compare disease detection of myeloma using contemporary whole-body (WB) MRI and fluorine 18 (

Identifiants

DOI: 10.1148/rycan.2021210048 PMID: 34559006 PMC: PMC8489453
pubmed: 34559006
doi: 10.1148/rycan.2021210048
pmc: PMC8489453
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Banques de données

ClinicalTrials.gov
['NCT02403102']

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e210048

Subventions

Organisme : Cancer Research UK
ID : C1491/A25351
Pays : United Kingdom
Organisme : Department of Health
ID : C1060/A10334
Pays : United Kingdom
Organisme : Department of Health
ID : C1060/A16464
Pays : United Kingdom

Références

Eur Radiol. 2019 Jul;29(7):3889-3900
pubmed: 30937589
Leukemia. 2013 Apr;27(4):947-53
pubmed: 23183429
J Magn Reson Imaging. 2020 May;51(5):1325-1335
pubmed: 31260155
J Clin Oncol. 2010 Mar 20;28(9):1606-10
pubmed: 20177023
Blood. 2014 Jan 2;123(1):78-85
pubmed: 24144643
Radiology. 2019 Apr;291(1):5-13
pubmed: 30806604
Blood. 2016 Jun 16;127(24):2955-62
pubmed: 27002115
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):537-546
pubmed: 31776631
Br J Haematol. 1999 Mar;104(4):723-9
pubmed: 10192431
Magn Reson Imaging. 2021 Jan;75:60-64
pubmed: 33075451
J Clin Oncol. 2017 Sep 1;35(25):2911-2918
pubmed: 28686535
Lancet Oncol. 2019 Jun;20(6):e302-e312
pubmed: 31162104
Leuk Lymphoma. 2017 Oct;58(10):2298-2303
pubmed: 28264597
Radiology. 2014 Jun;271(3):785-94
pubmed: 24475858
Blood. 2017 Jul 6;130(1):30-34
pubmed: 28432222
Radiology. 2017 Feb;282(2):484-493
pubmed: 27610934
Lancet Oncol. 2014 Nov;15(12):e538-48
pubmed: 25439696
Eur Radiol. 2020 Jan;30(1):320-327
pubmed: 31267214
JCO Oncol Pract. 2020 Oct;16(10):e1169-e1180
pubmed: 32469686
J Clin Oncol. 1995 Jan;13(1):251-6
pubmed: 7799027
Haematologica. 2015 Jun;100(6):818-25
pubmed: 25795721
Eur Radiol. 2020 Apr;30(4):1927-1937
pubmed: 31844960
J Clin Oncol. 2015 Feb 20;33(6):657-64
pubmed: 25605835
Blood. 2009 Sep 3;114(10):2068-76
pubmed: 19443657
Haematologica. 2016 Apr;101(4):e142-4
pubmed: 26819048
Am J Nucl Med Mol Imaging. 2015 Oct 12;5(5):479-92
pubmed: 26550539
Leukemia. 2014 Sep;28(9):1902-8
pubmed: 24535407
Leukemia. 2016 Jun;30(6):1446-8
pubmed: 26648535
J Clin Oncol. 2014 Sep 20;32(27):3048-58
pubmed: 25113771
Radiology. 2020 Jun;295(3):606-615
pubmed: 32255416
Am J Hematol. 2012 Sep;87(9):861-4
pubmed: 22641455
Nat Commun. 2017 Aug 16;8(1):268
pubmed: 28814763
Crit Rev Oncol Hematol. 2018 Apr;124:66-72
pubmed: 29548488
Leukemia. 2006 Sep;20(9):1467-73
pubmed: 16855634
Leukemia. 2009 Sep;23(9):1545-56
pubmed: 19421229
N Engl J Med. 2013 Aug 1;369(5):438-47
pubmed: 23902483
AJR Am J Roentgenol. 2019 Sep;213(3):514-523
pubmed: 31166755
Ann Oncol. 2005 Nov;16(11):1824-8
pubmed: 16087694
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2558-2565
pubmed: 33469686

Auteurs

Christina Messiou (C)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
ORCID: 0000-0002-0557-9379

Nuria Porta (N)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
ORCID: 0000-0003-2458-2167

Bhupinder Sharma (B)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Daniel Levine (D)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Dow-Mu Koh (DM)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Kevin Boyd (K)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Charlotte Pawlyn (C)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Angela Riddell (A)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Katherine Downey (K)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

James Croft (J)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Veronica Morgan (V)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Simon Stern (S)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Betty Cheung (B)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
ORCID: 0000-0003-1050-9487

Charalampia Kyriakou (C)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Pawel Kaczmarek (P)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Jessica Winfield (J)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
ORCID: 0000-0001-6069-5252

Matthew Blackledge (M)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Wim J G Oyen (WJG)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
ORCID: 0000-0001-8235-7078

Martin F Kaiser (MF)

From the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Glucides › Désoses › Désoxyglucose › Fluorodésoxyglucose F18 › Prospective Evaluation of Whole-Body MRI...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation cellulaire › Transplantation de cellules souches › Transplantation de cellules souches hématopoïétiques › Prospective Evaluation of Whole-Body MRI...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Prospective Evaluation of Whole-Body MRI...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Imagerie par résonance magnétique › Prospective Evaluation of Whole-Body MRI...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Prospective Evaluation of Whole-Body MRI...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Paraprotéinémies › Myélome multiple › Prospective Evaluation of Whole-Body MRI...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › Prospective Evaluation of Whole-Body MRI...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Prospective Evaluation of Whole-Body MRI...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation autologue › Prospective Evaluation of Whole-Body MRI...